Latest Insider Transactions at Alphatec Holdings, Inc. (ATEC)
This section provides a real-time view of insider transactions for Alphatec Holdings, Inc. (ATEC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alphatec Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alphatec Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 10
2021
|
David R Pelizzon |
BUY
Open market or private purchase
|
Direct |
120,000
+30.86%
|
$1,800,000
$15.25 P/Share
|
May 10
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,000
+50.0%
|
$42,000
$14.5 P/Share
|
May 10
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,000
+9.95%
|
$56,000
$14.38 P/Share
|
May 03
2021
|
David Sponsel EVP, SALES |
SELL
Open market or private sale
|
Direct |
30,000
-4.78%
|
$450,000
$15.97 P/Share
|
May 03
2021
|
David Sponsel EVP, SALES |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+2.36%
|
$90,000
$3.52 P/Share
|
Apr 29
2021
|
Patrick Miles CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
146,074
-2.86%
|
$2,337,184
$16.33 P/Share
|
Apr 29
2021
|
Kelli Mari Howell EVP, CLINICAL STRATEGIES |
SELL
Payment of exercise price or tax liability
|
Direct |
11,474
-2.19%
|
$183,584
$16.33 P/Share
|
Apr 29
2021
|
Brian Snider EVP, MARKETING |
SELL
Payment of exercise price or tax liability
|
Direct |
20,080
-3.04%
|
$321,280
$16.33 P/Share
|
Apr 29
2021
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
SELL
Payment of exercise price or tax liability
|
Direct |
22,381
-2.03%
|
$358,096
$16.33 P/Share
|
Apr 26
2021
|
David Sponsel EVP, SALES |
SELL
Open market or private sale
|
Direct |
14,572
-2.38%
|
$233,152
$16.63 P/Share
|
Apr 19
2021
|
John Todd Koning CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
190,000
+33.7%
|
-
|
Apr 12
2021
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+8.32%
|
$200,000
$2.0 P/Share
|
Apr 09
2021
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
SELL
Open market or private sale
|
Direct |
5,840
-0.58%
|
$105,120
$18.0 P/Share
|
Apr 08
2021
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
SELL
Open market or private sale
|
Direct |
25,000
-2.42%
|
$400,000
$16.23 P/Share
|
Mar 25
2021
|
Brian Snider EVP, MARKETING |
SELL
Payment of exercise price or tax liability
|
Direct |
6,484
-0.97%
|
$103,744
$16.68 P/Share
|
Mar 10
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
3,000
+3.11%
|
$48,000
$16.38 P/Share
|
Mar 09
2021
|
James L L Tullis |
SELL
Open market or private sale
|
Indirect |
22,500
-3.96%
|
$360,000
$16.24 P/Share
|
Mar 09
2021
|
Jeffrey G. Black EVP & CFO |
SELL
Open market or private sale
|
Direct |
7,000
-1.12%
|
$112,000
$16.69 P/Share
|
Mar 08
2021
|
David R Pelizzon |
BUY
Open market or private purchase
|
Direct |
4,698
+1.55%
|
$70,470
$15.72 P/Share
|
Mar 01
2021
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
18,842
-5.74%
|
$301,472
$16.54 P/Share
|
Mar 01
2021
|
David R Pelizzon |
BUY
Open market or private purchase
|
Indirect |
8,100,810
+41.55%
|
$89,108,910
$11.11 P/Share
|
Feb 23
2021
|
James L L Tullis |
BUY
Other acquisition or disposition
|
Indirect |
131,870
+34.69%
|
-
|
Feb 23
2021
|
James L L Tullis |
SELL
Other acquisition or disposition
|
Indirect |
600,000
-40.23%
|
-
|
Feb 23
2021
|
James L L Tullis |
SELL
Open market or private sale
|
Indirect |
161,389
-8.29%
|
$2,582,224
$16.51 P/Share
|
Feb 23
2021
|
James L L Tullis |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
761,298
+27.63%
|
$2,283,894
$3.5 P/Share
|
Feb 23
2021
|
James L L Tullis |
SELL
Open market or private sale
|
Direct |
3,887
-2.58%
|
$62,192
$16.51 P/Share
|
Feb 23
2021
|
James L L Tullis |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
18,337
+10.84%
|
$55,011
$3.5 P/Share
|
Feb 18
2021
|
Scott Lish CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+9.64%
|
-
|
Feb 18
2021
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+4.62%
|
-
|
Feb 18
2021
|
Patrick Miles CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+0.97%
|
-
|
Feb 18
2021
|
David Sponsel EVP, SALES |
SELL
Grant, award, or other acquisition
|
Direct |
40,000
-6.13%
|
-
|
Feb 18
2021
|
Kelli Mari Howell EVP, CLINICAL STRATEGIES |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+3.68%
|
-
|
Feb 18
2021
|
Brian Snider EVP, MARKETING |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+2.91%
|
-
|
Feb 16
2021
|
Jeffrey G. Black EVP & CFO |
SELL
Open market or private sale
|
Direct |
25,000
-3.83%
|
$400,000
$16.28 P/Share
|
Jan 21
2021
|
James L L Tullis |
BUY
Other acquisition or disposition
|
Direct |
4,714
+3.44%
|
-
|
Jan 21
2021
|
James L L Tullis |
SELL
Other acquisition or disposition
|
Indirect |
400,000
-55.88%
|
-
|
Dec 18
2020
|
James L L Tullis |
SELL
Bona fide gift
|
Direct |
29
-0.02%
|
-
|
Dec 18
2020
|
David R Pelizzon |
BUY
Grant, award, or other acquisition
|
Indirect |
1,350,135
+35.65%
|
$14,851,485
$11.11 P/Share
|
Dec 01
2020
|
James L L Tullis |
BUY
Other acquisition or disposition
|
Indirect |
116,355
+50.0%
|
-
|
Dec 01
2020
|
James L L Tullis |
SELL
Other acquisition or disposition
|
Indirect |
600,000
-34.41%
|
-
|
Nov 16
2020
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,162
-0.73%
|
$19,458
$9.82 P/Share
|
Oct 12
2020
|
David Sponsel EVP, SALES |
SELL
Open market or private sale
|
Direct |
89,999
-13.6%
|
$809,991
$9.47 P/Share
|
Oct 08
2020
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
SELL
Open market or private sale
|
Direct |
62,731
-3.04%
|
$501,848
$8.63 P/Share
|